Rapid Detection of Group B Strep- 35-37 Week Study
Withdrawn before enrolling
Conditions studied: Group B Streptococcus Neonatal Sepsis
In brief
The purpose of this study is to determine whether a rapid bedside diagnosis of Group B Strep growing in the vagina and rectum can be performed with similar success to the routine culture.
Key facts
- Study ID
- NCT00331019
- Run by
- University of Michigan
- People needed
- 0
- Starts
- 2006-07-01
- Last updated by the study team
- 2015-12-15
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Women 18 years of age or older
- Mentally capable of giving informed consent
- Presentation for regularly scheduled 35-37 week cultures
You may not qualify if…
- Inability to give informed consent
- Evidence of ruptured membranes by clinical or laboratory criteria
- Use of any antibiotic within the previous 7 days
Where it is running
- University of Michigan Hospital — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.